Center-Authored Papers

Filters: Author is Buchbinder, Susan  [Clear All Filters]
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 
Viral Load
Gray G, Buchbinder S, Duerr A.  2010.  Overview of STEP and Phambili trial results: two phase IIb test-of-concept studies investigating the efficacy of MRK adenovirus type 5 gag/pol/nef subtype B HIV vaccine.. Current opinion in HIV and AIDS. 5(5):357-61. Abstract
Vaccine and Infectious Disease Division
Celum C, Baeten JM, Hughes JP, Barnabas R, Liu A, van Rooyen H, Buchbinder S.  2013.  Integrated strategies for combination HIV prevention: principles and examples for men who have sex with men in the Americas and heterosexual African populations.. Journal of acquired immune deficiency syndromes (1999). 63 Suppl 2:S213-20. Abstract
Tieu H-V, Li X, Donnell D, Vittinghoff E, Buchbinder S, Parente ZG, Koblin B.  2013.  Anal sex role segregation and versatility among men who have sex with men: EXPLORE Study.. Journal of acquired immune deficiency syndromes (1999). 64(1):121-5. Abstract
Arnold MP, Andrasik M, Landers S, Karuna S, Mimiaga MJ, Wakefield S, Mayer K, Buchbinder S, Koblin BA.  2014.  Sources of Racial/Ethnic Differences in Awareness of HIV Vaccine Trials.. American journal of public health. :e1-e7. Abstract
Novak RM, Metch B, Buchbinder S, Cabello R, Donastorg Y, Figoroa J-P, Abdul-Jauwad H, Adbul-Jauwad H, Joseph P, Koenig E et al..  2013.  Risk behavior among women enrolled in a randomized controlled efficacy trial of an adenoviral vector vaccine to prevent HIV acquisition.. AIDS (London, England). 27(11):1763-70. Abstract
Hertz T, Ahmed H, Friedrich DP, Casimiro DR, Self SG, Corey L, McElrath MJ, Buchbinder S, Horton H, Frahm N et al..  2013.  HIV-1 vaccine-induced T-cell responses cluster in epitope hotspots that differ from those induced in natural infection with HIV-1.. PLoS pathogens. 9(6):e1003404. Abstract
Gray G, Buchbinder S, Duerr A.  2010.  Overview of STEP and Phambili trial results: two phase IIb test-of-concept studies investigating the efficacy of MRK adenovirus type 5 gag/pol/nef subtype B HIV vaccine.. Current opinion in HIV and AIDS. 5(5):357-61. Abstract
Marzinke MA, Clarke W, Wang L, Cummings V, Liu T-Y, Piwowar-Manning E, Breaud A, Griffith S, Buchbinder S, Shoptaw S et al..  2013.  Nondisclosure of HIV Status in a Clinical Trial Setting: Antiretroviral Drug Screening Can Help Distinguish Between Newly Diagnosed and Previously Diagnosed HIV Infection.. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America. Abstract
Rolland M, Tovanabutra S, Decamp AC, Frahm N, Gilbert PB, Sanders-Buell E, Heath L, Magaret CA, Bose M, Bradfield A et al..  2011.  Genetic impact of vaccination on breakthrough HIV-1 sequences from the STEP trial.. Nature medicine. 17(3):366-71. Abstract
Koblin BA, Mayer KH, Eshleman SH, Wang L, Mannheimer S, del Rio C, Shoptaw S, Magnus M, Buchbinder S, Wilton L et al..  2013.  Correlates of HIV Acquisition in a Cohort of Black Men Who Have Sex with Men in the United States: HIV Prevention Trials Network (HPTN) 061.. PloS one. 8(7):e70413. Abstract
Mayer KH, Wang L, Koblin B, Mannheimer S, Magnus M, del Rio C, Buchbinder S, Wilton L, Cummings V, Watson CC et al..  2014.  Concomitant Socioeconomic, Behavioral, and Biological Factors Associated with the Disproportionate HIV Infection Burden among Black Men Who Have Sex with Men in 6 U.S. Cities.. PloS one. 9(1):e87298. Abstract
Duerr A, Huang Y, Buchbinder S, Coombs RW, Sanchez J, del Rio C, Casapia M, Santiago S, Huang Y, Gilbert P et al..  2013.  Reply to richie and villasante.. The Journal of infectious diseases. 207(4):690-2.
Duerr A, Huang Y, Buchbinder S, Coombs RW, Sanchez J, del Rio C, Casapia M, Santiago S, Gilbert P, Corey L et al..  2012.  Extended Follow-up Confirms Early Vaccine-Enhanced Risk of HIV Acquisition and Demonstrates Waning Effect Over Time Among Participants in a Randomized Trial of Recombinant Adenovirus HIV Vaccine (Step Study).. The Journal of infectious diseases. 206(2):258-266. Abstract
Janes H, Gilbert P, Buchbinder S, Kublin J, Sobieszczyk ME, Hammer SM.  2013.  In Pursuit of an HIV Vaccine: Designing Efficacy Trials in the Context of Partially Effective Non-Vaccine Prevention Modalities.. AIDS research and human retroviruses. Abstract
T-Lymphocytes, Cytotoxic
Rolland M, Tovanabutra S, Decamp AC, Frahm N, Gilbert PB, Sanders-Buell E, Heath L, Magaret CA, Bose M, Bradfield A et al..  2011.  Genetic impact of vaccination on breakthrough HIV-1 sequences from the STEP trial.. Nature medicine. 17(3):366-71. Abstract
Substance-Related Disorders
Novak RM, Metch B, Buchbinder S, Cabello R, Donastorg Y, Figoroa J-P, Abdul-Jauwad H, Adbul-Jauwad H, Joseph P, Koenig E et al..  2013.  Risk behavior among women enrolled in a randomized controlled efficacy trial of an adenoviral vector vaccine to prevent HIV acquisition.. AIDS (London, England). 27(11):1763-70. Abstract
South America
Novak RM, Metch B, Buchbinder S, Cabello R, Donastorg Y, Figoroa J-P, Abdul-Jauwad H, Adbul-Jauwad H, Joseph P, Koenig E et al..  2013.  Risk behavior among women enrolled in a randomized controlled efficacy trial of an adenoviral vector vaccine to prevent HIV acquisition.. AIDS (London, England). 27(11):1763-70. Abstract
South Africa
Gray G, Buchbinder S, Duerr A.  2010.  Overview of STEP and Phambili trial results: two phase IIb test-of-concept studies investigating the efficacy of MRK adenovirus type 5 gag/pol/nef subtype B HIV vaccine.. Current opinion in HIV and AIDS. 5(5):357-61. Abstract
Sexual Behavior
Novak RM, Metch B, Buchbinder S, Cabello R, Donastorg Y, Figoroa J-P, Abdul-Jauwad H, Adbul-Jauwad H, Joseph P, Koenig E et al..  2013.  Risk behavior among women enrolled in a randomized controlled efficacy trial of an adenoviral vector vaccine to prevent HIV acquisition.. AIDS (London, England). 27(11):1763-70. Abstract
September 2013
Tieu H-V, Li X, Donnell D, Vittinghoff E, Buchbinder S, Parente ZG, Koblin B.  2013.  Anal sex role segregation and versatility among men who have sex with men: EXPLORE Study.. Journal of acquired immune deficiency syndromes (1999). 64(1):121-5. Abstract
Risk-Taking
Novak RM, Metch B, Buchbinder S, Cabello R, Donastorg Y, Figoroa J-P, Abdul-Jauwad H, Adbul-Jauwad H, Joseph P, Koenig E et al..  2013.  Risk behavior among women enrolled in a randomized controlled efficacy trial of an adenoviral vector vaccine to prevent HIV acquisition.. AIDS (London, England). 27(11):1763-70. Abstract
Public Health Sciences Division
Duerr A, Huang Y, Buchbinder S, Coombs RW, Sanchez J, del Rio C, Casapia M, Santiago S, Huang Y, Gilbert P et al..  2013.  Reply to richie and villasante.. The Journal of infectious diseases. 207(4):690-2.
Janes H, Gilbert P, Buchbinder S, Kublin J, Sobieszczyk ME, Hammer SM.  2013.  In Pursuit of an HIV Vaccine: Designing Efficacy Trials in the Context of Partially Effective Non-Vaccine Prevention Modalities.. AIDS research and human retroviruses. Abstract
Celum C, Baeten JM, Hughes JP, Barnabas R, Liu A, van Rooyen H, Buchbinder S.  2013.  Integrated strategies for combination HIV prevention: principles and examples for men who have sex with men in the Americas and heterosexual African populations.. Journal of acquired immune deficiency syndromes (1999). 63 Suppl 2:S213-20. Abstract
PREGNANCY
Novak RM, Metch B, Buchbinder S, Cabello R, Donastorg Y, Figoroa J-P, Abdul-Jauwad H, Adbul-Jauwad H, Joseph P, Koenig E et al..  2013.  Risk behavior among women enrolled in a randomized controlled efficacy trial of an adenoviral vector vaccine to prevent HIV acquisition.. AIDS (London, England). 27(11):1763-70. Abstract